Immunology and Microbiology
Allergic Inflammation
50%
Alpha-5 Beta-1
12%
B Cell
50%
Beta-Adrenergic Agonist
8%
Blocking Antibody
6%
Blood Plasma
7%
CCL17
14%
CCL22
14%
Chemoattractant
20%
CXCL10
34%
CXCL11
17%
Dander
8%
Enzyme-Linked Immunosorbent Assay
6%
Eosinophil Granulocyte
88%
Gamma Chemokine
10%
Growth Factor
8%
Homogenate
7%
Immunoglobulin E
12%
Inflammation
30%
Inflammatory Cell
9%
Influenza
6%
Isotype
50%
Leukocyte Recruitment
50%
Lung
30%
Macrophage
19%
Matrix Protein
12%
Monocyte
66%
Neutralization
6%
Phosphodiesterase-4 Inhibitor
50%
Platelet
50%
Severe Asthma
50%
Smooth Muscle
31%
Thymic Stromal Lymphopoietin
100%
Western Blot
6%
Pharmacology, Toxicology and Pharmaceutical Science
3 (3 Cyclopentyloxy 4 Methoxybenzyl) 6 Ethylamino 8 Isopropyl 3h Purine
50%
Anti-Inflammatory Drug
10%
Beta2 Agonist
27%
Biological Activity
8%
Budesonide Plus Formoterol
50%
Clinical Study
6%
Clinical Trial
5%
Corticosteroid
5%
Drug Delivery
12%
Fluticasone Propionate
50%
Formoterol
100%
Human
50%
Inhalation
92%
Intrinsic Resistance
12%
Mometasone Furoate
50%
Normal Human
100%
Pharmacodynamics
50%
Phosphodiesterase III Inhibitor
8%
Reslizumab
50%
Salmeterol
11%
Scanning Electron Microscopy
19%
Terbutaline
44%
Medicine and Dentistry
Adenosine Phosphate
50%
Asthma
50%
Beck Depression Inventory
12%
Beta 2 Adrenergic Receptor Stimulating Agent
6%
Bronchodilating Agent
12%
Budesonide/Formoterol
50%
Cells
6%
Drug
6%
Eosinophil
25%
Etiology
12%
Hyperventilation
50%
Induced Sputum
18%
Inflammatory Cell
6%
Inhalation
22%
Lung
37%
Marker
6%
Methacholine
25%
Morbidity
12%
Oxygen
12%
Patient
31%
Patient with Asthma
12%
Pattern of Breathing
12%
Respiratory Tract Inflammation
25%
Symptom
12%
Therapeutic Procedure
34%
